The abstract is read at the publisher; the summary is JClub's.
In a staged single-site programme in 31 adults reporting depressive symptoms, stroboscopic light stimulation showed low mean discomfort (0.49/10) with no severe adverse reactions.
- Why it matters: Safety, tolerability, and feasibility are needed before efficacy testing, and active-comparator design is required to manage subjective visual effects that could unmask treatment.
- What they did: Across three studies, 11 SLS parameter sets were screened for safety, an active comparator tested experiential separation in healthy adults, and 84 participants were randomized to four weekly 31-minute strobe-emphasis versus wash-emphasis sessions.
- The result: In the randomized study, endpoint data were available for 70/84 (83.3%) with no serious SLS-attributable adverse events, but the experiential separation seen in Study 2 was not reproduced between groups in Study 3.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.